Randomized controlled trial of the combination of exercise therapy and BCAA supplementation for chronic liver diseases
Phase 3
- Conditions
- chronic liver disease
- Registration Number
- JPRN-UMIN000001893
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with poor oral intake 2. Pasthistory of allergic reaction to the ingredients of Aminofeel 3.Patients with risky varices for upper GI bleeding 4. Patients of diabetes with poor control of the concentration of blood sugar 5. Patients of hypertention with poor control of blood pressure 6. Patients with history of severe cardiovascular diseases 7.Patients with clinical manifestation of hepatic encephalopathy 8.Patients inappropriate for participating to this study decided by the attending physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method utritional status after 6 weeks from the registration
- Secondary Outcome Measures
Name Time Method Symptoms, quality of life of patients and immunological competences after 6 weeks from the registration